23andMe
in respiratory disease beyond | 23andMe
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
38 of 39
Related slides by other companies
Genprex
Investor Presentation
October 2022
in small cell lung cancer | Genprex
Cytek
Investor Day
June 2022
mapping the landscape of the lung in pneumococcal pneumonia nature antigen presentation by epithelial cell function and regulates barrier immunity i | Cytek
AN2 Therapeutics
IPO
March 2022
antibacterial activity in a chronic model of mac lung disease in showed improved antibacterial activity of at all doses compared to the daily humanized dose of lung disease in mice against an therapeutics | AN2 Therapeutics
Compass Therapeutics
Investor Presentation
May 2023
partial response in a patient with small cell lung cancer i | Compass Therapeutics
Other recent decks by 23andMe
See all presentations (7 decks)
Investor Presentation
April 2023
Investor Presentation
August 2022
Investor Presentation
February 2022
Investor Day
January 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io